The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7

Journal of Virology - United States
doi 10.1128/jvi.00057-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Structural Studies of the pRB Tumor Suppressor Complexed With Human Papillomavirus E7.

1998English

PTPN14 Degradation by High-Risk Human Papillomavirus E7 Limits Keratinocyte Differentiation and Contributes to HPV-mediated Oncogenesis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Human Papillomavirus Type 16 Nucleoprotein E7 Is a Tumor Rejection Antigen.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Destabilization of the Retinoblastoma Tumor Suppressor by Human Papillomavirus Type 16 E7 Is Not Sufficient to Overcome Cell Cycle Arrest in Human Keratinocytes

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

The Human Papillomavirus E6 and E7 Inducible Oncogene, hWAPL, Exhibits Potential as a Therapeutic Target

British Journal of Cancer
Cancer ResearchOncology
2005English

Dimerization of the Human Papillomavirus E7 Oncoproteinin Vivo

Virology
Virology
1995English

The Bantam MicroRNA Is a Target of the Hippo Tumor-Suppressor Pathway

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2006English

Prometastatic GPCR CD97 Is a Direct Target of Tumor Suppressor microRNA-126

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2013English

Human Papillomavirus Type 16 E7 Oncoprotein mediatesCCNA1promoter Methylation

Cancer Science
Cancer ResearchMedicineOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy